Pneumococcal Conjugate Vaccine Does Not Influence Staphylococcus aureus Carriage in Young Children with Acute Otitis Media
Citations Over TimeTop 12% of 2007 papers
Abstract
We investigated nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus among infants and young children with acute otitis media in a country where use of 7-valent pneumococcal conjugate vaccine (PCV7) has been progressively implemented. Among 1783 children enrolled, 60.8% carried S. pneumoniae, and 9% carried S. aureus. Among S. pneumoniae carriers, the rate of S. aureus carriage was 8.4%, compared with 9.9% among S. pneumoniae noncarriers. The rate of S. pneumoniae carriage in the PCV7-vaccinated population was lower (59.8%) than that observed in the nonvaccinated population (66.2%; P1 year, the booster dose induces a sharp reduction in the carriage of vaccine serotypes of S. pneumoniae, without any change in S. aureus carriage.
Related Papers
- → Impact of the 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of Streptococcus pneumoniae Among Children Attending Group Daycare in Southeastern France(2015)28 cited
- → Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants(2021)18 cited
- → Prediction of acute otitis media with symptoms and signs(1995)22 cited
- → The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age(2003)27 cited
- → PEY12 IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE ON ACUTE OTITIS MEDIA IN YOUNG CHILDREN IN THE UNITED STATES, 1997–2004(2007)1 cited